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Identification of the functional 
pathways altered by placental cell 
exposure to high glucose: lessons 
from the transcript and metabolite 
interactome
C. H. Hulme  1,2, A. Stevens  3, W. Dunn4,5,6, A. E. P. Heazell1,2, K. Hollywood4,5,7, P. Begley4,5, 
M. Westwood1,2 & J. E. Myers1,2
The specific consequences of hyperglycaemia on placental metabolism and function are incompletely 
understood but likely contribute to poor pregnancy outcomes associated with diabetes mellitus (DM). 
This study aimed to identify the functional biochemical pathways perturbed by placental exposure to 
high glucose levels through integrative analysis of the trophoblast transcriptome and metabolome. 
The human trophoblast cell line, BeWo, was cultured in 5 or 25 mM glucose, as a model of the placenta 
in DM. Transcriptomic analysis using microarrays, demonstrated 5632 differentially expressed gene 
transcripts (≥± 1.3 fold change (FC)) following exposure to high glucose. These genes were used to 
generate interactome models of transcript response using BioGRID (non-inferred network: 2500 nodes 
(genes) and 10541 protein-protein interactions). Ultra performance-liquid chromatography-mass 
spectrometry (MS) and gas chromatography-MS analysis of intracellular extracts and culture medium 
were used to assess the response of metabolite profiles to high glucose concentration. The interactions 
of altered genes and metabolites were assessed using the MetScape interactome database, resulting 
in an integrated model of systemic transcriptome (2969 genes) and metabolome (41 metabolites) 
response within placental cells exposed to high glucose. The functional pathways which demonstrated 
significant change in response to high glucose included fatty acid β-oxidation, phospholipid metabolism 
and phosphatidylinositol phosphate signalling.
Pregnancies complicated by diabetes mellitus (DM) are associated with poor maternal and perinatal outcomes. 
These include birth trauma1, stillbirth2 and pre-eclampsia3, however fetal overgrowth is the most common 
adverse outcome4,5. Infants with fetal macrosomia, diagnosed as those with a customised birth weight centile 
of 90 or greater, are more likely to develop metabolic syndrome in adulthood6,7. Whilst the association between 
maternal hyperglycaemia and excessive fetal growth is long established, the contribution of altered placental func-
tion to this relationship is incompletely understood4. Several studies have suggested that placental-fetal nutrient 
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supply is altered in these pregnancies8–13. The molecular mechanisms that contribute to such dysfunction are 
poorly defined, although placental nutrient sensing pathways, such as the mammalian target of the rapamycin 
(mTOR) pathway14,15, and alterations in placental lipid metabolism13,16 have been implicated. The objective of the 
study presented here was to build on these observations regarding individual molecules and pathways by using a 
systems biology approach to obtain a holistic biochemical view of the placental response to high glucose.
Interactome networks that represent the transcript, metabolite and integrated transcript and metabolite 
response of a trophoblast cell line (BeWo) to culture in high glucose were generated. This method allows the 
visualisation and interpretation of complex interactions between large numbers of molecules17 and can there-
fore be used as a method of integrating multiple ‘omic datasets to provide an understanding of organisational 
complexity within the system18. Interactome networks are made up of nodes - the individual objects being stud-
ied, e.g., genes or metabolites - and edges - the connections between the objects, e.g., known protein-protein or 
protein-metabolite interactions19. Nodes that share large numbers of connections tend to share similar biological 
functions19. Therefore studying groups of proteins or proteins and metabolites that are highly interconnected, 
known as modules, can be used to identify key functions within an interactome network19. Conducting inter-
actome network analysis alongside pathway ontology analysis, using tools such as Ingenuity Pathway Analysis 
(IPA)20, allows greater confidence in the selection of candidate pathways or molecules for further study as these 
are based on two independent methods of mapping the data, known protein-protein interactions and text mining, 
respectively.
Here we perform network and pathway analyses on transcript and metabolite data generated from an in 
vitro model of the placental trophoblast exposed to high glucose levels. These data reveal known, and impor-
tantly, novel functional pathways likely to be disrupted as a consequence of placental exposure to maternal 
hyperglycaemia.
Materials and Methods
All reagents were purchased from Sigma-Aldrich unless stated.
Cell Culture and Sample Preparation. BeWo cells (passage 10; n = 6; originally from the European 
Collection of Animal Cell Cultures, Porton Down; mycoplasma negative) were cultured on T75 and T225 flasks 
(Corning) (both seeded at 1.6 × 106 cells/cm2), for transcriptomics and metabolomics, respectively. The number 
of replicates was based on similar numbers having been successfully used in other metabolomics studies where 
human samples were used, therefore less variability would exist in this cohort21. Cells were cultured for 24 hours 
in 1:1 DMEM:F12 containing 5 mM glucose and 10% fetal bovine serum (FBS), which was then exchanged for 
1:1 DMEM:F12 containing either 5 mM (representing normoglycaemia) or 25 mM (representing hyperglycae-
mia;22,23) glucose and 10% FBS for a further 48 h. Preliminary studies were completed in which MTT assays were 
used to confirm that high glucose conditions (30 mM) did not affect cell viability compared to standard culture 
in 17 mM glucose (94 ± 34% (median ± IQR); n = 6; p > 0.05; Wilcoxon signed rank). Cells used for the analysis 
of RNA were lysed directly in Trizol® reagent (Invitrogen, UK), whereas those used for internal metabolome 
analysis were washed and quenched within 2.5 minutes of removing the conditioned medium (CM), scraped into 
suspension then subjected to 4 cycles of freezing with liquid nitrogen (60 s) and thawing on ice. CM was centri-
fuged (10,000 g; 10 min) and the supernatant was snap-frozen for analysis of the external metabolome. Cells and 
CM were stored at −80 °C until analysis.
Microarray Analysis. Total RNA was isolated from the cell lysate using a Trizol® Plus RNA Purification Kit 
(Ambion, Paisley), according to the manufacturers’ instructions. RNA integrity and concentration was deter-
mined using a Nanodrop spectrophotometer and Agilent bioanalyzer. (Thermo Scientific, USA). Equal concen-
trations of RNA from each experimental replicate (n = 6) were pooled to an overall concentration of 95ng/μl and 
one microarray per experimental group was assessed.
The pooled samples were analysed using Affymetrix exon arrays (Affymetrix, High Wycombe, UK). 
Background correction, quantile normalization, gene expression analysis and robust multiarray analysis (RMA) 
of the data were completed in Bioconductor (Bolstad et al., 2003). Technical quality control and outlier analyses 
were performed using Affymetrix dChip software (Version 2005). Genes that had a fold change (FC) ≥  ± 1.3 
between cells cultured in 25 mM compared to 5 mM glucose were identified for further analyses. Similar fold 
change cut-offs are commonly used for such network and pathway analysis approaches24,25. Partial least square 
discriminant analysis (PLS-DA) was applied using the MixOmics R-package26,27 and used to compare the fold 
changes of the selected genes to the unselected genes. Further assessment of specificity was performed by gener-
ating an affinity matrix from the gene expression data using the SNFtools R-package28 then t distributed stochastic 
neighbourhood embedding (tSNE) [Rtsne R-package29 was applied to show the clustering of genes with similar 
expression.
Metabolomic Analysis. Two independent chromatography-mass spectrometry (MS) assays for metabo-
lome analysis of the BeWo cells and conditioned CM were used to ensure that a wide range of polar and lipophilic 
metabolites were investigated. Full details of these methods are described in supplementary methods section A.
BeWo cells and CM were prepared as described previously21,30 (Supplementary Methods A1 and A2). Briefly, 
samples were lyophilised, then reconstituted in 50:50 Methanol:water for UPLC-MS analysis. Dried GC-MS sam-
ples were chemically derivatised via a process of methoxyimation then trimethylsilylation and then a retention 
marker solution was added. A quality control (QC) sample was prepared from a pool of all individual samples and 
for GC-MS analysis, succinic acid d4 was added as an internal standard to each sample.
Supplementary sections A4 and A5 detail complete methods for Ultra Performance Liquid-Chromatography 
MS. Samples were analysed in negative electrospray and positive ion modes on an Accela Ultra High 
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Performance Liquid Chromatograph, coupled on-line to an electrospray LTQ-Orbitrap hybrid mass spectrom-
eter (ThermoFisher Scientific, Hemel Hempstead, UK). The run order of samples was randomised. Data were 
processed using XCalibur (ThermoFisher Scientific, Bremen, Germany); applied in XCMS31 to assess relative 
quantification; chromatographic peaks were used to define the individual metabolic features and these features 
were matched according to accurate mass of metabolites by applying the software PUTMEDID_LCMS32. Putative 
(MSI level 2) and definitive identifications (MSI level 1) are reported.
Full details of the Gas Chromatography-Mass Spectrometry (GC-MS) analysis process are given in supple-
mentary sections A6 and A7. Sample analysis was performed, within 24 h of derivatisation, using an Agilent 6890 
gas chromatograph and 7673 autosampler (Agilent Technologies, Stockport, UK) attached to a LECO Pegasus III 
mass spectrometer (LECO Corporation, Stockport, UK). Pre-processing of GC-MS data was carried out, in which 
analyst-defined chromatographic peaks were associated with a retention index (RI) and electron impact (EI) 
mass spectrum for all samples and inputted into a study-specific peak list. Chromatographic peak deconvolution 
was performed for each sample and metabolite peaks were matched to peaks present in the study-specific list if 
defined criteria were met (RI ± 10, mass spectral (EI) match > 700). Peak areas were normalised to the succinic 
acid standard to generate a response ratio. Detected metabolite peaks were chemically identified by applying a 
search of the EI mass spectrum and RI in mass spectral libraries; the Golm metabolite library33, the National 
Institute for Standards in Technology database (NIST/EPA/NIH08 (NIST, 2010)), as well as over 500 entries in the 
MMD mass spectral/RI library34. Putative (MSI level 2) and definitive identifications (MSI level 1) are reported.
Multivariate analysis followed by Kruskal-Wallis testing of metabolite data were used to determine statistically 
significant differences (p < 0.01) in metabolite abundance between CM or cells cultured in 25 mM compared to 
5 mM glucose. Only metabolites that could be assigned a PubChem ID, and that showed a differential abundance 
of ≥  ± 1.3 FC were used to analyse metabolite changes via pathway or network analysis.
Pathway and network analysis of the transcriptome and metabolome. An overview of the 
approach taken is shown in Fig. 1. The key processes used to identify functional pathways altered in response to 
exposure of trophoblast to high glucose levels are detailed below.
Network analysis of the transcriptome. The interactions between the differentially expressed genes were 
assessed using the BioGRID interactome database (v3.2.99) in Cytoscape (v2.8.3) to generate network models 
based on protein-protein interaction (either, only the genes identified from the array data (non-inferred nodes), 
or from the genes identified through the array analysis along with their inferred interactions (inferred nodes)35). 
Two independent mathematical algorithms, ClusterOne (v0.93)36 and Moduland (v2.8.3)37, were applied to the 
interactome networks in Cytoscape (v2.8.3) to identify highly connected clusters of proteins (modules) that are 
functionally central to the interactome network (ClusterOne) and that demarcate the hierarchical structure of 
the interactome network (Moduland). Modules identified using the ClusterOne algorithm were ranked based 
on their connectivity. Non-significant modules (p ≥ 0.05) were removed from further analysis. The biological 
function of each module was assessed by analysing the proteins identified within each cluster using the pathway 
analysis tool in Reactome software38. The significance of the pathway functions identified in Reactome was deter-
mined by Fisher’s exact test and p ≤ 0.05 was considered statistically significant.
Pathway analysis. Genes that were differentially expressed and metabolites that were differentially abun-
dant between cells exposed to 25 mM glucose compared to 5 mM glucose were analysed using pathway enrich-
ment analysis (Ingenuity, Qiagen, US) to identify and visualize the affected canonical pathways. Pathways with 
p ≤ 0.05 were considered as statistically significant (Fisher’s exact test).
Network analysis of a previously published transcriptome dataset of the murine placenta in a 
model of diabetes mellitus. We ensured that the functional pathways identified in this study were altered 
as a specific response of trophoblast, rather than just a choriocarcinoma cell line, to high glucose, by conducting a 
thorough NCBI PubMed search to identify published datasets of the placental transcriptome response to hyperg-
lycaemia or diabetes mellitus (see full details in the supplementary methods section C). The data from a study that 
employed streptozotocin to induce DM in mice as a model of type 1 diabetes mellitus (T1 DM)39 were used to gen-
erate an inferred network from placental genes that were differentially expressed in the murine placental model 
of T1 DM compared to untreated mice ( ± 1.6 FC). Genes that overlapped between the BeWo analysis of 25 mM 
compared to 5 mM glucose and the mouse model of T1 DM, were then imported into a new inferred network. 
ClusterOne and Moduland algorithms were then applied to identify central gene clusters, as described above.
Integrated network analysis of the transcriptome and metabolome. Differentially abundant 
metabolites (±1.3 FC) and genes (±1.3 FC) were analysed using the MetScape plugin (v2.0)40 in Cytoscape 
(v2.8.3) and networks generated based on known protein-protein and protein-metabolite interactions. The met-
abolic pathways which were associated with protein-metabolite interactions were mapped onto each of the net-
works to highlight the pathways with large numbers of gene and metabolite changes that were central within the 
network.
Investigation of gene expression changes in an ex vivo placental explant model of high glucose 
and in placentas from women with T1DM. Collection and processing of placental samples and culture of 
term placental villous explants. Placentas were obtained with maternal informed, written consent in accordance 
with Local Research Ethics Committee approval (08/H1010/55, Manchester, UK). Placentas were collected within 
30 minutes of delivery of a singleton infant at term (36 to 41 weeks gestation). Samples were taken from the cen-
tre, middle and edge of the placenta. Placental tissue was collected from women with T1 DM (n = 6) and BMI 
matched controls (BMI ≤ 30; n = 6). Patient demographics are shown in Supplementary Demographic Table 1. 
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Gestation, birth weight and individualised birth centile (IBC) were also different across the groups, as women 
with T1DM, were delivered at approximately 36 weeks of gestation and gave birth to larger infants.
Placental explants were made as previously described41 from term placentas of uncomplicated pregnancies 
(Supplementary Demographic Table 2). Three placental explants were cultured per netwell in 1.8 ml of warmed 
CM (1:1 DMEM:F12), containing 5 mM DMEM:F12 and 10% FCS, overnight. CM was then replaced with 1.8 ml 
of either 5 mM or 25 mM D-glucose CM, containing 10% FBS for a further 48 hours.
All placental tissues, from explants or pregnancies complicated by DM were stored in RNAlater for later RNA 
extraction. Total RNA was extracted from placental explants and tissue using a Purelink RNA Mini kit (Ambion, 
Figure 1. Overview of the workflow used to identify functional pathways which are altered within placental 
trophoblast cells in response to high glucose.
www.nature.com/scientificreports/
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Life Technologies) and quantified using a nanodrop (Nanodrop 2000c, ThermoScientific), according to manufac-
turer’s instructions. 250 ng RNA was used for reverse transcription (RT) and cDNA was generated as described 
previously42. RNA from the placental explant experiments, was pooled from 6 explants per experimental condi-
tion (each from separate netwells) for each of six placentas.
Quantitative real time- polymerase chain reaction (qRT-PCR) analysis of genes within the phosphatidylinosi-
tol phosphate pathway. qRT-PCR was used to corroborate the microarray data by assessing the effect of 
glucose on the expression of a subset of genes, choosing genes coding for proteins within the phosphatidy-
linositol phosphate pathway (AMP-Activated Kinase Alpha (AMPKα), Mammalian Target of Rapamycin 
(mTOR), P70 S6-Kinase (P70S6K) and 3-Phosphoinositide Dependent Protein Kinase 1 (PDK1)) as this 
pathway was identified by network and pathway analysis of the transcriptome, as well as the integrated tran-
scriptome and metabolome to be functionally important in the BeWo cell response to high glucose. Further 
these genes were also assessed in samples derived from placental explants from uncomplicated pregnan-
cies cultured in 5 mM or 25 mM glucose (Supplementary Methods B2 and B3) for 48 hours and placen-
tal tissue from women with and without T1DM (Supplementary Methods B4). Genes of interest were 
quantified using Brilliant III Ultra-Fast QPCR Master Mix (Agilent Technologies) on a MX3000 machine. 
qPCR reaction mixtures using standard (1×) primer concentration (0.25 μM) were made including the 
following primers: AMPKα F:ACCAGGTGATCAGCACTCCA, R:TCTCTTCAACCCGTCCATGC; 
mTOR  F : TG T TC C G AC G A ATC TC A A AG C ,  R : TC ATATG T TC C TG G C AC AG C C ;  P 7 0 S 6 K 
F:GAGCTGGAGGAGGGGG, R:CCATGCAAGTTCATATGGTCC; PDK1 F:GGCCCAGAGTTGCTCAGAAT 
R: GCACTGGACTAACTGCCCAT. All samples were run in duplicate. 40 cycles of 95 °C for 3 minutes, 60 °C for 
20 seconds and 72 °C for 30 seconds were performed. A standard curve was created from human reference RNA 
(1 µg/µl stock) ranging from 0.781 ng to 100 ng. Primer specificity was confirmed by analysis of dissociation 
curves generated within each run and by the inclusion of no RT and no cDNA controls’. Each of the genes was 
normalised to the mean of two reference genes, 18 S ribosomal RNA and Topoisomerase 1; both of which showed 
no difference in expression in response to 25 mM compared to 5 mM glucose.
Results
Gene changes in BeWo cells following culture in 25 mM compared to 5 mM glucose. The expres-
sion of 5632 gene transcripts, from the 133673 identified, differed ( ≥  ± 1.3 FC) between BeWo cells cultured in 
25 mM compared to 5 mM glucose (Supplementary Table 1). PLS-DA analysis confirmed a significant difference 
(p < 0.001) between the genes with ≥  ± 1.3 fold change in expression and those that were altered to a lesser 
degree. Further analysis of the genes with ≥  ± 1.3 fold change in expression revealed 5 clusters, which map to 
pathways including lipid, (p value: 2.0 × 10−6 – 1.1 × 10−2), amino acid (p value: 1.0 × 10−2 – 1.6 × 10−2) and 
carbohydrate metabolism (p value: 1.5 × 10−3 – 7.6 × 10−3; Supplemental Fig. 1).
The 5632 genes defined as differentially expressed were used to generate two interactome networks using 
the BioGRID human interactome database. The first network contained only genes that were identified as 
altered by the microarray analysis (non-inferred network) and consisted of 2500 nodes (genes) and 10541 edges 
(protein-protein interactions). The second network was generated based on identified genes along with their 
inferred interacting partner genes (inferred network) and consisted of 10840 nodes and 59594 edges.
Assessment of the networks hierarchy, using the Moduland algorithm, highlighted several modules 
(Supplementary Table 2); of the top ten (ranked by network centrality), three were common to the inferred and 
non-inferred networks (Fig. 2). The functions of the most hierarchically central modules (and the central protein 
associated with these modules/module name) within the non-inferred network were: phosphoinositide 3-kinase 
(PI3K) cascade (MDM2; p = 0.003), glucose metabolism (SUMO2; p = 0.004), peroxisomal lipid metabolism 
(HSP90AA1; p = 0.009), phospholipid metabolism (ELAVL1; p = 9 × 10−4) and signalling by Bone morphoge-
netic protein (BMP) (SMAD2; p = 3.9 × 10−7). Similarly, functions of the hierarchically central modules in the 
inferred network of transcript response to high glucose included: regulation of TP53 activity through acetylation 
(SUMO2; p = 1.49 × 10−2), cellular response to stress (VHL; p = 2.3 × 10−13), polyubiquitination of a substrate 
(HSP90AA1; p = 0.016), circadian clock (CUL1; p = 0.0003) and regulation of lipid metabolism by peroxisome 
proliferator-activated receptor alpha (HDAC1; p = 0.007).
The ClusterOne algorithm generated 15 and 19 significant modules from the non-inferred and inferred 
interactome networks, respectively. The functions most significantly associated with the genes making up the 
most significant modules overlapped with those associated with the ModuLand-derived modules. Within the 
non-inferred network, these functions included: translation initiation (p = 2.32 × 10−28, Fisher’s exact test), 
glucose metabolism (p = 0.006), eIF2 activation (p = 0.002) and IGF1R signalling (p = 0.01). Modules identi-
fied within the inferred network (ClusterOne) were associated with lipoprotein metabolism (p = 0.004), insulin 
processing (p = 0.0005), circadian clock (p = 9 × 10−4) and peroxisomal lipid metabolism (p = 8.87 × 10−13). A 
summary of the modules identified using these algorithms and the functions associated with these modules are 
included in Supplementary Tables 2 and 3.
Pathway analysis, using the pathway enrichment tools in Ingenuity, suggested that the gene changes identified 
as a consequence of 25 mM compared to 5 mM glucose are likely to impact on numerous canonical pathways, 
many of which were confirmatory of the functional pathways associated with the interactome-derived mod-
ules. Altered functional pathways included, regulation of p70S6K signaling (p = 5.62 × 10−7), IGF-1 signaling 
(p = 4.51 × 10), insulin receptor signaling (p = 2.01 × 10−9) and mTOR signaling (p = 8.43 × 10−4).
Network analysis of a previously published transcriptome dataset of the murine placenta in a model of diabetes 
mellitus. 80 genes overlapped between the murine model of T1 DM and the model of BeWo cells cultured 
in 25 mM glucose (Supplementary Table 6). An interactome network was generated which consisted of 1560 
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nodes and 1968 edges. Application of ClusterOne and ModuLand algorithms to the network identified 18 and 
46 significant clusters, respectively. Functions of these clusters included regulation of lipid metabolism by per-
oxisome proliferator-activated receptor alpha (PPARα) and PI3K phosphorylation of phosphatidylinositol 
4,5-bisphosphate (PIP2) to phosphatidylinositol (3,4,5)-trisphosphate (PIP3) (Supplementary Table 7). Full 
details of these results are included in the supplementary results section C.
Investigation of transcript changes of the phosphatidylinositol phosphate pathway using quantitative real time- 
polymerase chain reaction (qRT-PCR). Table 1 demonstrates that altered expression of key genes within the 
phosphatidylinositol phosphate pathway, which were highlighted in the microarray analysis (AMPKα, mTOR, 
P70S6K and PDK1), could be confirmed using qRT-PCR. Assessment of expression of these genes in an inde-
pendent sample set (n = 6) again demonstrated median FC differences with comparable levels of FC in the same 
direction of change as those from the microarray. Furthermore, the expression of these genes was assessed in an 
ex vivo explant model of high glucose, with three of the genes showing differential expression in the same direc-
tion as in the BeWo model. In the placentas (n = 6) from women with DM, AMPKα and P70S6K demonstrated 
differential expression in the same direction as the BeWo cells.
Metabolite changes in BeWo cells and their conditioned culture media following culture in 
25 mM compared to 5 mM glucose. All experimental replicates were included in the metabolomic 
analyses. The effect of glucose on the metabolic footprint (conditioned CM) of BeWo cells was assessed using 
UPLC-MS and GC-MS. UPLC-MS analysis revealed that 51 metabolites were significantly different in the CM 
from BeWo cells exposed to 25 mM glucose (p ≤ 0.01) (Supplementary Table 4). The metabolites were categorised 
based on their class and the majority that were classifiable were found to be fatty acids and related metabolites 
Figure 2. The ModuLand algorithm was applied to inferred and non-inferred interactome networks of gene 
changes (±1.3 FC) seen in BeWo cells cultured in 25 mM glucose compared to 5 mM glucose. Modules were 
identified from the network and are ranked based on their hierarchical network connectivity. Three modules 
were identified in both the inferred and non-inferred interactome networks.
www.nature.com/scientificreports/
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(9 metabolites). GC-MS analysis identified only citrulline that was significantly increased (2.8 fold) in CM from 
BeWo cells cultured in 25 mM compared to 5 mM glucose (p = 0.004). BeWo cells (metabolic fingerprint) demon-
strated 27 metabolites with significant differences between culture in 25 mM and 5 mM glucose (p ≤ 0.01), when 
assessed by UPLC-MS (Supplementary Table 5). GC-MS analysis identified 3 metabolites that were all increased 
in BeWo cells cultured in 25 mM compared to 5 mM glucose (Stearic acid, FC = 1.29, p = 0.02; Heptadecanoic 
acid, FC = 1.30, p = 0.03; Hexadecanoic acid, FC = 1.25, p = 0.05).
Pathway analysis of the metabolites within the BeWo cells and secreted culture medium suggested that the 
superpathways of Serine and Glycine Biosynthesis I (p = 3.71 × 10−3) and glycine biosynthesis I (p = 4.4 × 10−3) 
are altered as a result of exposure of BeWo cells to high glucose levels. The molecular and cellular functions 
likely to be altered included amino acid metabolism (p = 2.25 × 10−11) and small molecule biochemistry 
(p = 2.25 × 10−11).
Interactome network analysis of the transcriptome and metabolome of BeWo cells following 
culture in 25 mM compared to 5 mM glucose. An interactome network model (Fig. 3A) representing 
the integrated transcriptome and metabolome (intracellular and extracellular metabolites) response of BeWo cells 
to culture in 25 mM versus 5 mM glucose was generated which included 2969 of the differentially expressed genes 
and 41 of the differentially abundant metabolites that were connected via protein-protein or protein-metabolite 
interactions (Fig. 3). Analysis of this interactome network suggested that several biological functions are likely to 
be altered by changes to glucose concentrations. These modules included genes and/or metabolite interactions 
which were associated with purine metabolism, phosphatidylinositol phosphate metabolism and glycerophos-
pholipid metabolism. The specific genes and metabolites within these modules are demonstrated in Fig. 3B and 
the differentially expressed/abundant genes and metabolites associated with these functional modules are high-
lighted in Fig. 3C.
Discussion
The aim of this study was to identify transcripts and metabolites that were altered in trophoblast in response to 
high glucose and to then integrate these changes, using a systems-biology approach. Thus, ultimately aiming 
to characterise the molecular phenotype of the placental trophoblast in an interactome model, from which the 
functional pathways likely to be perturbed in placentas exposed to maternal hyperglycaemia could be identified. 
Although several candidate pathways were identified from individually analysing the transcriptome and metab-
olome data, interrogation of an integrated interactome model provides greater confidence that the pathways 
identified, which include some that have previously been associated with placental dysfunction in pregnancies 
complicated by DM as well as novel pathways, represent attractive candidates for future research relating to ther-
apeutic interventions to prevent fetal overgrowth.
The phosphatidylinositol phosphate pathway (identified in transcriptome and integrated transcriptome and 
metabolome analyses), a key determinant of cellular proliferation and apoptosis43, is known to be regulated by 
hyperglycaemia in other organs44,45. Altered placental growth, particularly increased placental size/weight, has 
been widely demonstrated in pregnancies complicated by fetal macrosomia46,47; therefore this altered size could 
be associated with dysregulated placental proliferation due to perturbed PI3K pathway signalling. Moreover 
myo-inositol, the metabolite which forms the basis for this secondary messenger system48, has been implicated 
in several neonatal conditions in which fetal growth is atypical as researchers have reported increased levels in 
urine of neonates with fetal growth restriction (FGR)49 and decreased levels in FGR infants who go on to display 
catch-up growth50. Our investigations, to assess the expression of key genes within this pathway both corroborate 
the microarray data and suggest that expression of at least some of the genes within this pathway were similarly 
altered in an ex vivo placental explant model of high glucose and primary placental tissue from pregnancies 
25 mM D-glucose compared to 5 mM D-glucose (Fold Change)
T1 DM compared 
to Controls with a 
BMI ≤ 30 (n = 6)
Trophoblast Cell model (BeWo): 
First experiment (pooled n = 6)
Trophoblast Cell 
model (BeWo): Second 
experiment (n = 6)
Explant Model 
(n = 6)
From Microarray From qRT-PCR From qRT-PCR From qRT-PCR From qRT-PCR
AMP-activated Protein Kinase 
Alpha (AMPKα)
−1.43 −1.79 −1.71 (1.48) −1.21 (1.86) −2.6
Mammalian Target of 
Rapamycin (mTOR) +1.58 +1.57 +3.0 (3.00) −1.06 (1.49)  +1.15
P70 S6-Kinase (P70S6K) −1.15 −1.87 −3.0 (3.88) −1.36 (1.95) −1.61
3-Phosphoinositide Dependent 
Protein Kinase 1 (PDK1) +1.43 +1.67 +1.14 (2.97) +2.66 (2.79) −1.08
Table 1. Investigation of microarray data using qRT-PCR. RNA from six independent cultures of BeWo that 
had been pooled for analysis by microarray was analysed by qRT-PCR to determine the expression of a select 
panel of genes in order to investigate the microarray data. The median (IQR) fold change in gene expression 
observed in BeWo cells (n = 6) and placental explants (n = 6) cultured in 25 mM D-glucose compared to 5 mM 
D-glucose with the addition of 10% FCS is demonstrated; red = up-regulation and green = down-regulation. 
The fold change in gene expression that was observed in placental tissue from pregnancies complicated by type 
1 diabetes mellitus (T1DM) compared to BMI-matched controls was calculated from the median expression 
values in each experimental group.
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Figure 3. Network analysis of integrated gene and metabolite changes in BeWo cells cultured in 25 mM glucose 
compared to 5 mM glucose. (A) 5632 genes and 41 metabolites that were differentially expressed (±1.3 FC) 
in BeWo cells following 48 h culture in 25 mM compared to 5 mM glucose were used to derive an interaction 
network inferred using MetScape (3.1.1) as visually represented here; dark blue circles represent gene changes 
seen in the BeWo dataset, light blue circles represent inferred gene interactions, dark red circles represent 
metabolite changes seen in the BeWo dataset, light red circles represent inferred metabolite interactions, grey 
lines represent protein-protein or protein-metabolite interactions. (B) Table of the metabolic pathways with the 
greatest number of gene and metabolite changes that were identified from the integrated gene and metabolite 
interactome network. Genes or metabolites shown in red were up-regulated, whereas those in green were down-
regulated.
www.nature.com/scientificreports/
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complicated by DM as well as the BeWo trophoblast cell line. Together these observations suggest that this path-
way warrants further investigation.
The three analyses of transcript, metabolite and integrated transcript/metabolite data have all indicated that 
trophoblast lipid metabolism is altered as a consequence of exposure to high glucose conditions. The placenta 
transports and metabolizes lipids essential for fetal development51 and it has been hypothesised that aberration 
in these functions may contribute to fetal macrosomia as excess lipid is supplied to the fetus, where it is stored 
within the fetal adipose tissue52. Some observations have supported this hypothesis in DM including: increased 
(39%) activity of placental lipoprotein lipase in insulin T1DM13 and decreased levels of β–fatty acid oxidation 
(FAO) in placentas of women with GDM16. Our study lends weight to this argument by suggesting that perturbed 
lipid metabolism, specifically β–FAO, may be a significant contributor to altered placental function in pregnancies 
complicated by DM directly as a consequence of hyperglycaemia.
Integration of our metabolome and transcriptome datasets proposed functional pathways not commonly 
associated with placental dysfunction in pregnancies complicated by DM, emphasising the potential of integra-
tive network approaches for the identification of pathways for further study. One of these functional pathways, 
purine metabolism has not been studied in detail in the placenta, however, altered metabolism of the purine 
adenosine has been associated with increased nitric oxide synthesis in the placental macro- and micro-vascular 
endothelium53. In other pregnancy complications nitrative stress (caused by excess nitric oxide production54) is 
attributable to poor placental function55,56, therefore similar biochemical processes could be effected in placentas 
of pregnancies complicated by DM.
Our study is not only important in highlighting functional pathways within trophoblast that may be altered 
in response to high glucose, but it also demonstrates how these pathways interact to lead to systemic dysfunction. 
The integrated network provides a global representation of the subtle gene and metabolite changes which exist 
within the trophoblast cells following short-term exposure to high glucose. In a complex disease such as DM, it is 
likely that the phenotype is not due to changes in one pathway or an individual gene/metabolite, but attributable 
to a number of smaller changes which may interact with one another to lead to overall dysfunction of the biolog-
ical network.
A major limitation of our study was that it relied on an in vitro trophoblast cell model of the placenta. The deci-
sion to use this model was driven by our ambitious aim to conduct a systems biology approach to generate and 
integrate large ‘omic datasets. Many of the studies which have been successful in utilising these approaches have 
done so using simple, highly controllable, single cell-type models57. Other studies have described the limitations 
of using the choriocarcinoma cell line, BeWo, as a model of trophoblast to investigate gene expression profiles as 
there are some disparities in basal gene expression when compared to primary trophoblast58,59. Encouragingly, 
we have determined that the expression of key genes within the phosphatidylinositol phosphate pathway are also 
altered in an ex vivo model of placental explant exposed to high glucose nonetheless, further studies are required 
to determine whether all of the candidate functional pathways identified in this study are similarly affected. In 
addition, the placenta contains a number of different cell types and therefore inclusion of whole placental tissue 
would have over complicated the analysis and significantly limited the interpretation of the data. Further analysis 
of a previously published transcriptomic dataset of the placenta in a murine model of T1 DM was included to 
ensure that the functional pathways identified in this study were altered as a specific response of trophoblast, 
rather than just a choriocarcinoma cell line, to high glucose. The functional pathways identified in the current 
study were highly conserved in the murine placental interactome network model, again adding greater con-
fidence to the assertion that the BeWo interactome model described here is representative of the trophoblast 
response to high glucose.
It should also be recognised that this study has analysed transcriptome data generated from pooled RNA sam-
ples run on microarrays without technical replicates. Although not ideal for analysis of individual gene changes, 
significant changes were confirmed using PLS-LA and our analyses provided additional robustness by investi-
gating how these genes contribute to a network of systemic by linking changes across the entire transcriptome. 
Moreover, these data have been integrated with metabolomic changes (including metabolites of known relevance 
to placental exposure to high glucose), thus adding a greater level of certainty that the interactome network gen-
erated in this study is likely to depict a model of the molecular phenotype of placenta in pregnancies complicated 
by hyperglycaemia. Furthermore, the expression of a panel of genes was determined by qRT-PCR analysis of the 
pooled samples used in the microarray, which supported the initial data and similar results were obtained when 
the same genes were assessed in a separate experiment, where samples from 6 independent replicates of BeWo 
cells exposed to high and low glucose for 48 h were analysed individually as well as in a pooled sample.
The work presented in this study is the first, to our knowledge, to investigate how trophoblast cells are altered 
by high glucose conditions using a systems biology approach. The interactome models generated in this study 
offer a unique insight into the complex interactions between placental genes and metabolites in response to high 
glucose and provides a platform for further in vivo or ex vivo studies to understand how the placenta responds to 
exposure to high glucose in pregnancies complicated by DM.
References
 1. Young, B. C. & Ecker, J. L. Fetal macrosomia and shoulder dystocia in women with gestational diabetes: Risks amenable to treatment? 
Curr Diab Rep. 13, 12–18 (2013).
 2. Syed, M., Javed, H., Yakoob, M. Y. & Bhutta, Z. A. Effect of screening and management of diabetes during pregnancy on stillbirths. 
BMC Public Health. 11, S2 (2011).
 3. Bradley, P. K., Duprey, M. & Castorino, K. Identifying Key Intervention Opportunities During a Pregnancy Complicated by 
Diabetes: a Review of Acute Complications of Diabetes During Pregnancy. Curr Diab Rep. 16, 17 (2016).
 4. Metzger, B. E. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes. 58, 453–459 (2009).
 5. Ornoy, A. Prenatal origin of obesity and their complications: Gestational diabetes, maternal overweight and the paradoxical effects 
of fetal growth restriction and macrosomia. Reprod Toxicol Elmsford NY. 32, 205–212 (2011).
www.nature.com/scientificreports/
1 0SCIENTIFIC RepoRts |  (2018) 8:5270  | DOI:10.1038/s41598-018-22535-y
 6. Metzger, B. E. et al. Amniotic fluid insulin concentration as a predictor of obesity. Arch Dis Child. 65, 1050–1052 (1990).
 7. Baptiste-Roberts, K., Nicholson, W. K., Wang, N. Y. & Brancati, F. L. Gestational diabetes and subsequent growth patterns of 
offspring: The national collaborative perinatal project. Matern Child Health J. 16, 125–132 (2012).
 8. Gaither, K., Quraishi, A. N. & Illsley, N. P. Diabetes alters the expression and activity of the human placental GLUT1 glucose 
transporter. J Clin Endocrinol Metab. 84, 695–701 (1999).
 9. Jansson, T., Wennergren, M. & Powell, T. L. Placental glucose transport and GLUT 1 expression in insulin-dependent diabetes. Am 
J Obstet Gynecol. 180, 163–168 (1999).
 10. Jansson, T. et al. Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. Diabetes. 51, 
2214–2219 (2002).
 11. Knopp, R. H., Bergelin, R. O., Wahl, P. W. & Walden, C. E. Relationships of infant birth size to maternal lipoproteins, apoproteins, 
fuels, hormones, clinical chemistries, and body weight at 36 weeks gestation. Diabetes. 34, 71–77 (1985).
 12. Lindegaard, M. LlS., Damm, P., Mathiesen, E. R. & Nielsen, L. B. Placental triglyceride accumulation in maternal type 1 diabetes is 
associated with increased lipase gene expression. J Lipid Res. 47, 2581–2588 (2006).
 13. Magnusson, A. L. et al. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in 
pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab. 89, 4607–4614 (2004).
 14. Jansson, N. et al. Activation of Placental mTOR Signaling and Amino Acid Transporters in Obese Women Giving Birth to Large 
Babies. J Clin Endocrinol Metab. 98, 105–13 (2013).
 15. Roos, S. et al. Regulation of amino acid transporters by glucose and growth factors in cultured primary human trophoblast cells is 
mediated by mTOR signaling. Am J Physiol Cell Physiol. 297, C723–C731 (2009).
 16. Visiedo, F. et al. High-glucose levels reduce fatty acid oxidation and increase triglyceride accumulation in human placenta. Am J 
Physiol Endocrinol Metab. 302, E205–12 (2013).
 17. Albert, R. & Barabasi, A. L. Statistical mechanics of complex networks. Rev Mod Phys. 74, 47–97 (2002).
 18. Costa, L. D. F., Rodrigues, F. A. & Cristino, A. S. Complex networks: the key to systems biology. Genet Mol Biol. 31, 591–601 (2008).
 19. Vidal, M., Cusick, M. E. & Barabási, A. L. Interactome networks and human disease. Cell. 144, 986–998 (2011).
 20. Ingenuity Qiagen. Ingenuity Knowledge Base. http://www.ingenuity.com/science/knowledge-base (2014).
 21. Dunn, W. B. et al. Changes in the metabolic footprint of placental explant-conditioned culture medium identifies metabolic 
disturbances related to hypoxia and pre-eclampsia. Placenta. 30, 974–980 (2009).
 22. Hahn, T. et al. Hyperglycaemia-induced subcellular redistribution of GLUT1 glucose transporters in cultured human term placental 
trophoblast cells. Diabetologia. 43, 173–180 (2000).
 23. Weiss, U. et al. Hyperglycaemia in vitro alters the proliferation and mitochondrial activity of the choriocarcinoma cell lines BeWo, 
JAR and JEG-3 as models for human first-trimester trophoblast. Diabetologia. 44, 209–219 (2001).
 24. Su, Y. & Zhang, Y. Identification of biological processes and genes for gestational diabetes mellitus. Arch Gynecol Obstet. 292, 635–40 
(2015).
 25. Hulme, C. H. et al. Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder 
profiles. Arthritis Res Ther. 19, 150 (2017).
 26. Rohart, F., Gautier, B., Singh, A. & Le Cao, K. W. MixOmics: An R package for’omics feature selection and multiple data integration. 
PLoS Comput Biol. 13, e1005752 (2017).
 27. RCoreTeam. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 
https://www.r-project.org/ (2016).
 28. Wang, B. et al. Similarity network fusion for aggregating data types on a genomic scale. Nat Methods. 11, 333–7 (2014).
 29. van der Maaten, L. & Hinton, G. Visualizing Data using t-SNE. J Mach Learn Res. 9, 2579–2605 (2008).
 30. Heazell, A. E. P. et al. Analysis of the metabolic footprint and tissue metabolome of placental villous explants cultured at different 
oxygen tensions reveals novel redox biomarkers. Placenta. 29, 691–698 (2008).
 31. Smith, C. A. et al. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, 
and identification. Anal Chem. 78, 779–787 (2006).
 32. Brown, M. et al. Automated Workflows for Accurate Mass-based Putative Metabolite Identification in LC/MS-derived Metabolomic 
Datasets. Bioinformatics. 27, 1108–1112 (2011).
 33. Golm Library. http://csbdb.mpimgolm.mpg.de/csbdb/gmd/msri/gmd_contributions.-html (2010).
 34. Brown, M. et al. Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics. Analyst. 
134, 1322–1332 (2009).
 35. Barabási, A.-L., Gulbahce, N. & Loscalzo, J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 12, 
56–68 (2011).
 36. Nepusz, T., Yu, H. & Paccanaro, A. Detecting overlapping protein complexes in protein-protein interaction networks. Math Comput 
Model. 52, 2066–2074 (2012).
 37. Szalay-Beko, M. et al. ModuLand plug-in for Cytoscape: Determination of hierarchical layers of overlapping network modules and 
community centrality. Bioinformatics. 28, 2202–2204 (2012).
 38. Vastrik, I. et al. Reactome: a knowledge base of biologic pathways and processes. Genome Biol 8, R39 (2007).
 39. Salbaum, J. M. et al. Altered gene expression and spongiotrophoblast differentiation in placenta from a mouse model of diabetes in 
pregnancy. Diabetologia. 54, 1909–1920 (2011).
 40. Karnovsky, A. et al. Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. 
Bioinformatics. 28, 373–380 (2012).
 41. Simán, C. M. et al. The functional regeneration of syncytiotrophoblast in cultured explants of term placenta. Am J Physiol Regul 
Integr Comp Physiol. 280, R1116–R1122 (2001).
 42. Sharp, A. N. et al. Preeclampsia is assosciated with alterations in the p53-pathway in villous trophoblast. PLoS One. 9, e87621 (2014).
 43. Manning, B. D. & Cantley, L. C. AKT/PKB signaling:navigating downstreat. Cell. 129, 1261–74 (2007).
 44. Huang, Q. & Sheibani, N. High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and 
ERKs. Am J Physiol Cell Physiol. 295, C1647–C1657 (2008).
 45. Qin, D., Zhang, G., Xu, X. & Wang, L. The PI3K/Akt Signaling Pathway Mediates the High Glucose-Induced Expression of 
Extracellular Matrix Molecules in Human Retinal Pigment Epithelial Cells. J Diabetes Res. 2015, e9920280 (2015).
 46. al-Okail, M. S. & al-Attas, O. S. Histological changes in placental syncytiotrophoblasts of poorly controlled gestational diabetic 
patients. Endocr J. 41, 355–360 (1994).
 47. Mayhew, T. M., Sørensen, F. B., Klebe, J. G. & Jackson, M. R. Growth and maturation of villi in placentae from well-controlled 
diabetic women. Placenta. 15, 57–65 (1994).
 48. Jones, D. R. & Varela-Nieto, I. The role of glycosyl-phosphatidylinositol in signal transduction. Biochem Cell Biol. 30, 313–326 
(1998).
 49. Dessì, A. et al. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic 
syndrome. J Matern neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 24, 35–9 (2011).
 50. Stevens, A. et al. Insights into the pathophysiology of catch-up compared with non-catch-up growth in children born small for 
gestational age: an integrated analysis of metabolic and transcriptomic data. Pharmacogenomics J 14, 376–384 (2014).
 51. Dutta-Roy, A. K. Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta. Am J Clin Nutr. 71, 
315S–22S (2000).
www.nature.com/scientificreports/
1 1SCIENTIFIC RepoRts |  (2018) 8:5270  | DOI:10.1038/s41598-018-22535-y
 52. Szabo, A. J. & Szabo, O. Placental free-fatty-acid transfer and fetal adipose-tissue development: an explantation of fetal adiposity in 
infants of diabetic mothers. Lancet. 2, 498–499 (1974).
 53. Pardo, F. et al. Role of equilibrative adenosine transporters and adenosine receptors as modulators of the human placental 
endothelium in gestational diabetes mellitus. Placenta. 34, 1121–1127 (2013).
 54. Pacher, P., Beckman, J. S. & Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 87, 315–424 (2007).
 55. Lyall, F., Greer, I. A., Young, A. & Myatt, L. Nitric oxide concentrations are increased in the feto-placental circulation in intrauterine 
growth restriction. Placenta. 17, 165–168 (1996).
 56. Myatt, L. et al. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension. 28, 488–493 (1996).
 57. Lu, R. et al. Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature. 462, 358–362 (2009).
 58. Bilban, M. et al. Trophoblast invasion: assessment of cellular models using gene expression signatures. Placenta. 31, 989–96 (2010).
 59. Novakovic, B. et al. Wide ranging DNA methylation differences of primary trophoblast cell populations and derived-cell lines: 
implications and opportunities for understanding trophoblast function. Mol Hum Reprod. 17, 344–353 (2011).
Acknowledgements
Thanks go to the Genomic Technologies Core Facility at The University of Manchester for running the Affymetrix 
microarrays. CHH was funded through a Manchester University Research Impact Scholarship award. The 
sponsors had no involvement in the study design, data collection and interpretation or preparation of the 
manuscript.
Author Contributions
C.H.H., J.M., M.W., W.D., A.E.P.H. and A.S. conception and design of research; C.H.H., K.H. and P.B. performed 
experiments; C.H.H., A.S., K.H. and P.B. analysed data; C.H.H., J.M., M.W., W.D., A.E.P.H. and A.S. interpreted 
results of experiments; C.H.H. prepared figures; C.H.H. drafted manuscripts; C.H.H., J.M., M.W., A.S., W.D., 
K.H., P.G. and A.E.P.H. edited and revised manuscript; C.H.H., J.M., M.W., W.D., A.E.P.H., A.S., K.H., P.B. 
approved final version of manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-22535-y.
Competing Interests: The authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2018
